PDB60 COST-EFFECTIVENESS OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U300 IN THE NETHERLANDS: EVIDENCE FROM A RANDOMISED CONTROLLED TRIAL (RCT) by Evans, M., Moes, R.J., Pedersen, K.S., Gundgaard, J.

Get full text

Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score by Tesch, Victoria Katharina, Abolhassani, Hassan, Shadur, Bella, Zobel, Joachim, Mareika, Yuliya, Sharapova, Svetlana, Karakoc-Aydiner, Elif, Rivière, Jacques G., Garcia-Prat, Marina, Moes, Nicolette, Haerynck, Filomeen, Gonzales-Granado, Luis I., Santos Pérez, Juan Luis, Mukhina, Anna, Shcherbina, Anna, Aghamohammadi, Asghar, Hammarström, Lennart, Dogu, Figen, Haskologlu, Sule, İkincioğulları, Aydan İ., Köstel Bal, Sevgi, Baris, Safa, Kilic, Sara Sebnem, Karaca, Neslihan Edeer, Kutukculer, Necil, Girschick, Hermann, Kolios, Antonios, Keles, Sevgi, Uygun, Vedat, Stepensky, Polina, Worth, Austen, van Montfrans, Joris M., Peters, Anke M.J., Meyts, Isabelle, Adeli, Mehdi, Marzollo, Antonio, Padem, Nurcicek, Khojah, Amer M., Chavoshzadeh, Zahra, Avbelj Stefanija, Magdalena, Bakhtiar, Shahrzad, Florkin, Benoit, Meeths, Marie, Gamez, Laura, Grimbacher, Bodo, Seppänen, Mikko R.J., Lankester, Arjan, Gennery, Andrew R., Seidel, Markus G.

Get full text

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals by Brüggemann, R.J., Moes, D.J.A.R., van Rhee, K.P., van 't Veer, N.E., Koch, B.C.P., van Rossum, M., Windsant - van den Tweel, A. Vermeulen, Reijers, M.H.E., van Kimmenade, R.R.J., Rahamat-Langedoen, J.C., Rettig, T.C.D., van Raalte, R., van Paassen, J., Polderman, F.N., van der Linden, P.D., Frenzel, T., de Mast, Q., Burger, D.M., Schouten, J., van de Veerdonk, F.L., Pickkers, P., ter Heine, R.

Get full text